Site Press Office
>
Le Groupe Solvay détient 95,33% des actions d'Innogenetics
Other Solvay Sites
------------------------------------------------
Solvay.com
---------- Business Portals ----------
Chemicals Portal
Plastics Portal
> Other sites by Businesses
----------- Country Portals -----------
Solvay Austria
Solvay Asia Pacific
Solvay China
Solvay Deutschland
Solvay France
Solvay Iberica
Solvay Italia
Solvay Nordic
Solvay North America
Solvay Portugal
Solvay Schweiz
> Other sites by Regions
Ce Site
Tous
SOLVAY.COM
PRESS OFFICE
Press Releases
All Releases
Environmental news
Financial news
Press Kit
Image Gallery
Corporate
Products
People
Plants
Research
Contacts
Headquarters
In your country
Asia pacific
Benelux
Brazil + MERCOSUR
Bulgaria
France
Germany
Italy
Portugal
Spain
United States
Pharmaceuticals Sector
Mailing List
Library
Annual Report
Environmental Report
Solvay at a Glance
Glossary
Solvay Worldwide
Press Release
version:
[EN]
-
[NL]
-
> 13 novembre, 2008<
Le Groupe Solvay détient 95,33% des actions d'Innogenetics
|
Envoyer par email
|
© Solvay S.A • Informations importantes :
Privacy policy
-
Disclaimer
• Pour tout commentaire, veuillez contacter le
webmaster
Date de dernière mise à jour: 17/2/2010
